Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Pacific Biosciences of California    PACB

PACIFIC BIOSCIENCES OF CALIFORNIA

(PACB)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/15/2019 08/16/2019 08/19/2019 08/20/2019 08/21/2019 Date
5.6(c) 5.76(c) 5.84(c) 5.74(c) 5.745 Last
796 805 701 198 1 432 342 616 001 142 945 Volume
+0.18% +2.86% +1.39% -1.71% +0.09% Change
More quotes
Financials (USD)
Sales 2019 98,9 M
EBIT 2019 -99,4 M
Net income 2019 -100 M
Finance 2019 97,6 M
Yield 2019 -
Sales 2020 133 M
EBIT 2020 -73,8 M
Net income 2020 -74,9 M
Finance 2020 100 M
Yield 2020 -
P/E ratio 2019 -8,78x
P/E ratio 2020 -12,1x
EV / Sales2019 7,89x
EV / Sales2020 5,85x
Capitalization 878 M
More Financials
Company
Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to help scientists resolve genetically complex problems. The Company is engaged in the development, manufacturing and marketing of an integrated platform for genetic analysis. Its Single Molecule,... 
More about the company
Surperformance© ratings of Pacific Biosciences of Cal
Trading Rating : Investor Rating :
More Ratings
Latest news on PACIFIC BIOSCIENCES OF CAL
08/06PACIFIC BIOSCIENCES : 2Q Earnings Snapshot
AQ
08/06PACIFIC BIOSCIENCES OF CALIFORNIA : Management's Discussion and Analysis of Fina..
AQ
08/06PACIFIC BIOSCIENCES OF CALIFORNIA, I : Results of Operations and Financial Condi..
AQ
08/06PACIFIC BIOSCIENCES OF CALIFORNIA : Announces Second Quarter 2019 Financial Resu..
AQ
08/06PACIFIC BIOSCIENCES OF CALIFORNIA : Beijing-Based Annoroad Increases SMRT Sequen..
PU
07/17EXCLUSIVE : Woodford biotech stakes first off block in asset sale - source
RE
06/18PACIFIC BIOSCIENCES OF CALIFORNIA, I : Submission of Matters to a Vote of Securi..
AQ
06/18PACIFIC BIOSCIENCES OF CALIFORNIA, I : Other Events (form 8-K)
AQ
06/18CMA says Illumina-Pacific Biosciences deal could hurt competition
RE
06/18ILLUMINA : takeover of PacBio raises competition concerns
AQ
More news
Analyst Recommendations on PACIFIC BIOSCIENCES OF CAL
More recommendations
Sector news : Advanced Medical Equipment & Technology - NEC
01:15aEXCLUSIVE : Philips, under investigation in U.S. and Brazil, fired whistleblower..
RE
08/15AGILENT TECHNOLOGIES : Up 8.3% After Earnings, Guidance
DJ
08/15Agilent Up Over 8%, on Pace for Largest Percent Increase Since November 2013 ..
DJ
08/14AGILENT TECHNOLOGIES : Posts Lower 3Q Profit, Raises Guidance
DJ
08/09GLOBAL MARKETS LIVE : Bayer, Huawei, Airbus, Occidental Petroleum…
More sector news : Advanced Medical Equipment & Technology - NEC
Chart PACIFIC BIOSCIENCES OF CALIFORNIA
Duration : Period :
Pacific Biosciences of California Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PACIFIC BIOSCIENCES OF CAL
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 4
Average target price 7,63  $
Last Close Price 5,74  $
Spread / Highest target 39,4%
Spread / Average Target 32,8%
Spread / Lowest Target 13,2%
EPS Revisions
Managers
NameTitle
Michael W. Hunkapiller Executive Chairman, President & CEO
Susan K. Barnes CFO, Principal Accounting Officer & Senior VP
Stephen W. Turner Chief Technology Officer
Jonas Korlach Chief Scientific Officer
William W. Ericson Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
PACIFIC BIOSCIENCES OF CALIFORNIA-22.43%878
THERMO FISHER SCIENTIFIC24.90%110 607
DANAHER CORPORATION35.83%100 482
BOSTON SCIENTIFIC CORPORATION20.94%59 201
INTUITIVE SURGICAL3.95%57 377
EDWARDS LIFESCIENCES CORPORATION45.26%46 171